Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III Read more
Positive phase III results show Roche’s giredestrant significantly improved progression-free survival in ER-positive advanced breast cancer Read more
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion Read more
CEA Industries Files Registration Statement for its $500M PIPE. CEO David Namdar Releases Letter to Shareholders Read more
ICEX and SOSA Launch Desafía San Francisco to Accelerate Spanish Startups in Silicon Valley Read more
Yangtze River Pharmaceutical Group’s Innovative Anti-insomnia Drug Fazamorexant Debut at the World Sleep Congress 2025 Read more
Buck Sexton: “If China gets it first – they stay first forever” — Former CIA Officer Reveals Urgent AI Race and a possible Bold Response Read more